Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Postel

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Phase I-II trial designs: how early should efficacy guide the dose recommendation process?X Paoletti, S Postel-Vinay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Phase I trials in oncology: a new era has startedS Postel-Vinay, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscapeK A Olaussen, S Postel-Vinay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2013
Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression?S Postel-Vinay, M Schlumberger, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonismD Morel, G Almouzni, J-C Soria, et al.
Protein Engineering, Design & Selection : PEDS|October 30, 2013
Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinityP Sharma, S Postel, E J Sundberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2018
Epigenetic modifiers as new immunomodulatory therapies in solid tumoursS Aspeslagh, D Morel, J-C Soria, et al.
Law, Medicine & Health Care : a Publication of the American Society of Law & Medicine|December 1, 1983
Standards of medical care based on consensus rather than evidence: the case of routine bedrail use for the elderlyH S Rubenstein, F H Miller, S Postel, et al.
Journal of the American College Health Association|February 1, 1976
Medical cost analysis of a defined population using a mixed delivery systemB Goldman, J L Bethune, M Peterson, et al.
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Phase I-II trial designs: how early should efficacy guide the dose recommendation process?X Paoletti, S Postel-Vinay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Phase I trials in oncology: a new era has startedS Postel-Vinay, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscapeK A Olaussen, S Postel-Vinay
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2013
Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression?S Postel-Vinay, M Schlumberger, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonismD Morel, G Almouzni, J-C Soria, et al.
Protein Engineering, Design & Selection : PEDS|October 30, 2013
Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinityP Sharma, S Postel, E J Sundberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2018
Epigenetic modifiers as new immunomodulatory therapies in solid tumoursS Aspeslagh, D Morel, J-C Soria, et al.
Law, Medicine & Health Care : a Publication of the American Society of Law & Medicine|December 1, 1983
Standards of medical care based on consensus rather than evidence: the case of routine bedrail use for the elderlyH S Rubenstein, F H Miller, S Postel, et al.
Journal of the American College Health Association|February 1, 1976
Medical cost analysis of a defined population using a mixed delivery systemB Goldman, J L Bethune, M Peterson, et al.
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
Pageof 4